GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nyxoah SA (XBRU:NYXH) » Definitions » Current Accrued Expense

Nyxoah (XBRU:NYXH) Current Accrued Expense : €6.21 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nyxoah Current Accrued Expense?

Nyxoah's Current Accrued Expense for the quarter that ended in Mar. 2024 was €6.21 Mil.

Nyxoah's quarterly Current Accrued Expense declined from Sep. 2023 (€6.45 Mil) to Dec. 2023 (€6.06 Mil) but then increased from Dec. 2023 (€6.06 Mil) to Mar. 2024 (€6.21 Mil).

Nyxoah's annual Current Accrued Expense increased from Dec. 2021 (€3.98 Mil) to Dec. 2022 (€7.53 Mil) but then declined from Dec. 2022 (€7.53 Mil) to Dec. 2023 (€6.06 Mil).

Nyxoah Current Accrued Expense Historical Data

The historical data trend for Nyxoah's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nyxoah Current Accrued Expense Chart

Nyxoah Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Accrued Expense
Get a 7-Day Free Trial 1.28 2.00 3.98 7.53 6.06

Nyxoah Quarterly Data
Dec17 Dec18 Jun19 Dec19 Mar20 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.17 5.54 6.45 6.06 6.21

Nyxoah Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Nyxoah Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Nyxoah's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Nyxoah (XBRU:NYXH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nyxoah SA (XBRU:NYXH) » Definitions » Current Accrued Expense
Comparable Companies
XTAE:ORBI XTAE:FBRT XTAE:BSEN XTAE:TATT XTAE:ISI ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN BAX XPAR:DIM HOLX TSE:7733 COO
Traded in Other Exchanges
NYXH:USA 5YI:Germany
Address
Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435
Website
https://www.nyxoah.com
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.